glaxosmithkline
astellas
theravance
vivus
Favorite
Share
Add To
bristol-myers squibb
ogeda
mylan
biogen
astrazeneca
merck & co.
glenmark
denosumab
johnson & johnson
embeda
roche
forest
almirall
emerging markets
osi
abbott
novartis
valeant
actavis
abbvie
pulmicort respules
merz
proton pump inhibitors
tl011
lumizyme
telaprevir
lung cancer
tarceva
